TrialBMC pharmacology & toxicology2019

A phase 1, randomized, open-label, single-dose study to assess the relative bioavailability of a subcutaneous dose of FKB327 when administered using a prefilled syringe, a prefilled auto-injector, or a vial with disposable syringe in healthy subjects.

Jim Bush et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.